Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)
China · Delayed Price · Currency is CNY 13.89
-0.18 (-1.28%)
Apr 9, 2026, 11:30 AM CST
SHA:600557 Revenue
Jiangsu Kanion Pharmaceutical had revenue of 701.11M CNY in the quarter ending September 30, 2025, a decrease of -17.42%. This brings the company's revenue in the last twelve months to 3.13B, down -29.97% year-over-year. In the year 2024, Jiangsu Kanion Pharmaceutical had annual revenue of 3.90B, down -19.86%.
Revenue (ttm)
3.13B
Revenue Growth
-29.97%
P/S Ratio
2.54
Revenue / Employee
511.02K
Employees
6,132
Market Cap
7.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.90B | -966.15M | -19.86% |
| Dec 31, 2023 | 4.86B | 512.95M | 11.79% |
| Dec 31, 2022 | 4.35B | 702.30M | 19.25% |
| Dec 31, 2021 | 3.65B | 616.64M | 20.34% |
| Dec 31, 2020 | 3.03B | -1.53B | -33.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Northeast Pharmaceutical Group | 7.07B |
| Renhe Pharmacy Co.,Ltd | 3.76B |
| Zhejiang Tianyu Pharmaceutical | 2.99B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.25B |
| Jiuzhitang | 2.23B |
| Guilin Sanjin Pharmaceutical | 2.08B |
| Guangxi Wuzhou Zhongheng Group | 1.75B |
| Hunan Warrant Pharmaceutical Co.,Ltd | 1.52B |